benzphetamine and fluoxetine
benzphetamine has been researched along with fluoxetine in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Beasley, CM; Goldstein, DJ; Masica, DN; Potvin, JH; Rampey, AH | 1 |
Reviews
1 review(s) available for benzphetamine and fluoxetine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Trials
1 trial(s) available for benzphetamine and fluoxetine
Article | Year |
---|---|
Analyses of suicidality in double-blind, placebo-controlled trials of pharmacotherapy for weight reduction.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Benzphetamine; Body Mass Index; Comorbidity; Depressive Disorder; Double-Blind Method; Drugs, Investigational; Female; Fluoxetine; Humans; Incidence; Male; Middle Aged; Obesity; Placebos; Substance Withdrawal Syndrome; Suicide | 1993 |
Other Studies
1 other study(ies) available for benzphetamine and fluoxetine
Article | Year |
---|---|
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |